Guifang Zhang

机构：First Affiliated Hospital of Xinxiang Medical University, Xinxiang Central Hospital, Henan Medical University · ORCID：0000-0002-8203-1884

发表论文 69 篇 · 总被引 753 次 · h-index 13

代表论文

• Anlotinib plus penpulimab versus sorafenib in the first-line treatment of unresectable hepatocellular carcinoma (APOLLO): a randomised, controlled, phase 3 trial (2025 · The Lancet Oncology · 被引 47)
• Effect of transcutaneous auricular vagus nerve stimulation on post-stroke dysphagia (2022 · Journal of Neurology · 被引 39)
• Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study (2023 · BMC Medicine · 被引 34)
• Capecitabine or Capecitabine Plus Oxaliplatin Versus Fluorouracil Plus Cisplatin in Definitive Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma (CRTCOESC): A Multicenter, Randomized, Open-Label, Phase 3 Trial (2024 · Journal of Clinical Oncology · 被引 17)
• Association Between Extraversion Personality With the Blood Pressure Level in Adolescents (2022 · Frontiers in Cardiovascular Medicine · 被引 14)
• Comparative study of clinical reasoning competence and self‐directed learning competence in nurses across varied years of experience (2024 · Journal of Clinical Nursing · 被引 12)